Results 21 to 30 of about 490,354 (259)
Infectious Disease Clinics of North America, 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic.
Li, Yijia, Li, Jonathan Z.
openaire +3 more sources
Acta Bio Medica Atenei Parmensis, 2021 One year has passed since the Sars-CoV-2 infection diagnosis was made in a patient hospitalized in Codogno unveiling the outbreak of coronavirus in Italy and the start of one of the worst pandemics in history. Today, we know a lot more about Covid-19 infection than we did a year ago.
openaire +3 more sources
Wiener klinische Wochenschrift, 2020 SummaryThe recent emergence of a new coronavirus (severe acute respiratory syndrome coronavirus‑2, SARS-CoV-2) that is transmitted efficiently among humans and can result in serious disease and/or death has become a global threat to public health and economy.
Heinz, Franz X., Stiasny, Karin
openaire +2 more sources
Pathogens, 2022 It has been posited SARS-CoV-2 contains at least one unique superantigen-like motif not found in any other SARS or endemic coronaviruses. Superantigens are potent antigens that can send the immune system into overdrive. SARS-CoV-2 causes many of the biological and clinical consequences of a superantigen, and, in the context of reinfection and waning ...
Adam Hamdy, Anthony Leonardi
openaire +3 more sources
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
Advanced Science, 2020 The world is currently experiencing a global pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes severe respiratory disease similar to SARS.
Yetian Dong +4 more
doaj +1 more source
Racing for a SARS‐CoV‐2 vaccine
EMBO Molecular Medicine, 2021 Graphical Abstract Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.
Özlem Türeci, Uğur Şahin
doaj +1 more source
On the origins of SARS-CoV-2 [PDF]
Nature Medicine, 2021 Stakeholders in public health must lobby policy makers to make decisions based on evidence, not political expediency, particularly when the studies that hang in the balance are critical to understanding the origins of epidemics.
openaire +2 more sources
Cardiovascular disease in SARS‐CoV‐2 infection
Clinical & Translational Immunology, 2021 Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease.
Kei Sato +5 more
doaj +1 more source
Radiographic findings of SARS‐CoV‐2 infection
Journal of the American College of Emergency Physicians Open, 2021 Study objective The 2019–20 coronavirus pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19).
Catherine A. Marco +9 more
doaj +1 more source
Subacute thyroiditis after SARS‐CoV‐2 infection
Clinical Case Reports, 2021 Viral infections are considered as etiologic factors of subacute thyroiditis. The true incidence of subacute thyroiditis, caused by SARS‐CoV‐2 infection, is probably considerable since it is often masked by more dramatic affection of the respiratory ...
Vasiliy I. Semikov +6 more
doaj +1 more source